Literature DB >> 32586899

Iron leakage owing to blood-brain barrier disruption in small vessel disease CADASIL.

Yuto Uchida1,2, Hirohito Kan3, Keita Sakurai4, Nobuyuki Arai3, Shohei Inui5, Susumu Kobayashi6, Daisuke Kato1, Yoshino Ueki7, Noriyuki Matsukawa8.   

Abstract

OBJECTIVE: To assess the relationship between iron accumulation, blood-brain barrier (BBB) damage, and cognitive function in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
METHODS: We enrolled 21 patients with NOTCH3 mutations and 21 age-matched healthy controls in this cross-sectional study. All participants underwent global physical and cognitive assessments and brain MRI, using voxel-based quantitative susceptibility mapping (QSM; iron deposition measure) and dynamic contrast enhanced MRI (DCE-MRI; BBB permeability measure). We compared behavioral and imaging data between the groups and analyzed the correlations in each group.
RESULTS: Among 21 NOTCH3 mutation carriers, 10 were symptomatic and 11 asymptomatic. Montreal Cognitive Assessment scores were significantly different among the groups (symptomatic < asymptomatic < control subjects). Voxel-based QSM analysis revealed that the symptomatic group had higher QSM values than did the asymptomatic group in the putamen, caudate nucleus, temporal pole, and centrum semiovale. These QSM values were positively correlated with regional BBB permeabilities (putamen: r = 0.57, p = 0.006; caudate nucleus: r = 0.51, p = 0.019; temporal pole: r = 0.48, p = 0.030; centrum semiovale: r = 0.45, p = 0.044) and negatively with Montreal Cognitive Assessment scores (caudate nucleus: r = -0.53, p = 0.012; temporal pole: r = -0.56, p = 0.008).
CONCLUSIONS: This study showed that cerebral iron burden was associated with regional BBB permeability and cognitive dysfunction in patients with CADASIL, highlighting the potential of these imaging techniques as auxiliary biomarkers to monitor the course of small vessel disease.
© 2020 American Academy of Neurology.

Entities:  

Year:  2020        PMID: 32586899     DOI: 10.1212/WNL.0000000000010148

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Magnetic Resonance Imaging of Blood-Brain Barrier permeability in Dementia.

Authors:  Audrey Chagnot; Samuel R Barnes; Axel Montagne
Journal:  Neuroscience       Date:  2021-08-13       Impact factor: 3.708

2.  Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease.

Authors:  Giuseppe Barisano; Axel Montagne; Kassandra Kisler; Julie A Schneider; Joanna M Wardlaw; Berislav V Zlokovic
Journal:  Nat Cardiovasc Res       Date:  2022-02-07

3.  Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses.

Authors:  Anya Topiwala; Chaoyue Wang; Klaus P Ebmeier; Stephen Burgess; Steven Bell; Daniel F Levey; Hang Zhou; Celeste McCracken; Adriana Roca-Fernández; Steffen E Petersen; Betty Raman; Masud Husain; Joel Gelernter; Karla L Miller; Stephen M Smith; Thomas E Nichols
Journal:  PLoS Med       Date:  2022-07-14       Impact factor: 11.613

4.  Imaging subtle leaks in the blood-brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions.

Authors:  Axel Montagne; Samuel R Barnes; Daniel A Nation; Kassandra Kisler; Arthur W Toga; Berislav V Zlokovic
Journal:  Geroscience       Date:  2022-04-25       Impact factor: 7.581

Review 5.  Waste Clearance in the Brain and Neuroinflammation: A Novel Perspective on Biomarker and Drug Target Discovery in Alzheimer's Disease.

Authors:  Kazuhiko Uchida
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

6.  Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM).

Authors:  Valerio Benedetti; Rosalia Canzoneri; Andrea Perrelli; Carlo Arduino; Andrea Zonta; Alfredo Brusco; Saverio Francesco Retta
Journal:  Antioxidants (Basel)       Date:  2022-06-29

Review 7.  Quantitative susceptibility mapping as an imaging biomarker for Alzheimer's disease: The expectations and limitations.

Authors:  Yuto Uchida; Hirohito Kan; Keita Sakurai; Kenichi Oishi; Noriyuki Matsukawa
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

8.  Effects of different regional cerebral blood flow on white matter hyperintensity in CADASIL patients.

Authors:  Runrun Wang; Jiewen Zhang; Junkui Shang; Fengyu Wang; Xi Yan
Journal:  J Biomed Res       Date:  2022-08-28

Review 9.  The pericyte: A critical cell in the pathogenesis of CADASIL.

Authors:  Marie-Magdeleine Ruchoux; Raj N Kalaria; Gustavo C Román
Journal:  Cereb Circ Cogn Behav       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.